Analytical validation of a novel panel of biomarkers for a test for preeclampsia
- 18 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 214, 114729
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Preeclampsia ScreeningJAMA, 2017
- Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected PreeclampsiaNew England Journal of Medicine, 2016
- Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2014
- Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsiaActa Obstetricia et Gynecologica Scandinavica, 2014
- Diagnostic Accuracy of Placental Growth Factor in Women With Suspected PreeclampsiaCirculation, 2013
- A leading role for the immune system in the pathophysiology of preeclampsiaJournal of Leukocyte Biology, 2013
- Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancyHypertension Research, 2013
- Preeclampsia: multiple approaches for a multifactorial diseaseDisease Models & Mechanisms, 2012
- New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complicationsThrombosis Research, 2011
- Mapping the Theories of Preeclampsia and the Role of Angiogenic FactorsObstetrics & Gynecology, 2007